English

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT NCT00079911

1 forms  
Study administration
Description

Study administration

Subject Identifier
Description

Subject Identifier

Data type

integer

Alias
UMLS CUI [1]
C2348585
INVESTIGATIONAL PRODUCT
Description

INVESTIGATIONAL PRODUCT

Investigational Product
Description

Check carefully for any overlapping start/stop date. Ensure any deviations from investigational product are recorded correctly as outlined in the study protocol. Record a new start and stop date if greater than or equal to one day of dosing is missed.

Data type

integer

Alias
UMLS CUI [1]
C0304229
Start date
Description

pharmacotherapy start date

Data type

date

Measurement units
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0808070
DD/MMM/YY
Stop date
Description

pharmacotherapy stop date

Data type

date

Measurement units
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0806020
DD/MMM/YY
Back to the top of the page

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT NCT00079911

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT
Item
Investigational Product
integer
C0304229 (UMLS CUI [1])
Investigational Product
Code List
Investigational Product
CL Item
Double-Blind therapy (23)
CL Item
Open-label treatment (24)
pharmacotherapy start date
Item
Start date
date
C0013216 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
pharmacotherapy stop date
Item
Stop date
date
C0013216 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Back to the top of the page